TWD
RPRX icon

True Wealth Design’s Royalty Pharma RPRX Stock Holding History

True Wealth Design’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.2K Buy
1,644
+141
+9% +$7.34K 0.02% 275
2026
Q1 		$72.1K Buy
1,503
+443
+42% +$19.4K 0.02% 296
2025
Q4 		$41K Sell
1,060
-31
-3% -$1.18K 0.01% 389
2025
Q3 		$38.5K Buy
1,091
+232
+27% +$8.4K 0.01% 392
2025
Q2 		$30.9K Buy
859
+15
+2% +$497 0.01% 289
2025
Q1 		$26.3K Buy
844
+45
+6% +$1.43K 0.01% 298
2024
Q4 		$20.4K Buy
+799
New +$21.2K 0.01% 319

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

True Wealth Design's RPRX Position: Q2 2026 in Review

True Wealth Design increased its Royalty Pharma (RPRX) stake by 9.4% in Q2 2026, buying an estimated $7.34K and bringing the position to 1,644 shares worth $92.2K. The position accounts for 0.02% of the portfolio, ranked #275.

True Wealth Design first reported a position in RPRX in Q4 2024 and has held it in 7 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • True Wealth Design held 1,644 shares of Royalty Pharma worth $92.2K as of Q2 2026.
  • True Wealth Design bought 141 Royalty Pharma shares in Q2 2026, an estimated $7.34K.
  • Royalty Pharma made up 0.02% of True Wealth Design's portfolio in Q2 2026, its #275 holding.
  • True Wealth Design first reported a position in Royalty Pharma in Q4 2024 and has held it in 7 quarters since.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.